Microsoft to Buy Rosetta Biosoftware to Integrate -Omics Analysis Tools into New Amalga Platform

Broadening its footprint in life sciences, Microsoft will buy "certain assets" of Rosetta Biosoftware, including its Resolver, Elucidator, and Syllego software packages.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.